BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Business

  Toyoda Gosei to Begin Collaboration With EBM Corporation in Developing Surgical Training Simulators Using e-Rubber

  Toyoda Gosei decided to work with EBM in order to achieve more life-like simulators by combining Toyoda Gosei’s e-Rubber technology.

  November 8, 2017

   · 

  2 min read
• Business

  Stephens & Associates Appoints an Internationally Recognized Dermatologist and a Senior Skin Scientist/Entrepreneur to Lead its New Phoenix Clinical Research Facility

  Stephens & Associates announces the appointment of Mark V. Dahl, MD, and Lawrence A. Rheins, PhD, to lead its newly-opened Phoenix research facility.

  November 8, 2017

   · 

  3 min read
• Business

  Regeneron Reports Third Quarter 2017 Financial and Operating Results

  In the third quarter of 2017, net sales of EYLEA in the United States increased 12% to $953M from $854M in the third quarter of 2016.

  November 8, 2017

   · 

  36 min read
• Business

  Hill-Rom Declares Fiscal 2018 First Quarter Dividend

  Hill-Rom announced today that its board of directors declared a fiscal 2018 first quarter dividend of $0.18 per share payable on December 29, 2017, to shareholders of record as of the close of business on December 15, 2017.

  November 8, 2017

   · 

  1 min read
• Business

  Eagle Pharmaceuticals Reports Third Quarter 2017 Results

  Total revenue for the third quarter of 2017 grew 67% to $63.0 million compared to $37.8 million in the third quarter of 2016.

  November 8, 2017

   · 

  19 min read
• Standigm, an AI Based Drug Discovery Company, Launched AI Drug Discovery Services Publicly at Bio-Europe 2017 in Berlin, Germany

  Bio-Europe is the Europe’s largest partnering conference for the biotechnology industry.

  November 8, 2017

   · 

  2 min read
• Business

  Sierra Oncology Reports Third Quarter Results

  Sierra Oncology therapeutics for the treatment of patients with cancer, today reported its financial and operational results for the third quarter ended September 30, 2017.

  November 8, 2017

   · 

  15 min read
• Biotech Bay

  AgeX Therapeutics VP of New Technology Discovery Aubrey de Grey to Serve on Aging & Longevity Panel at FT Global Pharmaceutical and Biotechnology Conference, November 9-10 in London

  The session, titled “Aging and Longevity,” and moderated by David Crow, Senior Business Correspondent at the Financial Times, is on Friday, November 10th at 12:10pm GMT.

  November 8, 2017

   · 

  4 min read
• Business

  Dermira and UCB Agree to End Collaboration Agreement for CIMZIA

  Dermira to transition development and commercialization responsibility for CIMZIA (certolizumab pegol) in psoriasis back to UCB.

  November 8, 2017

   · 

  11 min read
• FDA

  Chugai’s ALK Inhibitor “Alecensa” Approved for the Treatment of First Line Therapy on ALK-Positive Non-Small Cell Lung Cancer in the US

  Chugai Pharmaceutical announced today that Genentech, a member of the Roche Group, obtained approval from the U.S. FDA, for Alecensa in the treatment of “anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer”.

  November 8, 2017

   · 

  5 min read